Dr. Yasmine Belkaid obtained her Ph.D. in 1996 from the Pasteur Institute in France on innate responses to Leishmania infection. Following a postdoctoral fellowship at NIAID on immune regulation during Leishmania infection, she joined the Children’s Hospital Research Foundation in Cincinnati as an assistant professor in 2002. In 2005, she joined the NIAID Laboratory of Parasitic Diseases as a tenure-track investigator. Since 2008, she has worked as an adjunct professor at the University of Pennsylvania. Then, in 2021, Dr. Belkaid became the Chief of the newly created NIAID Laboratory of Host Immunity and Microbiome.
Chief of Operations
Dr. Jim Cherry obtained his Ph.D. from the Catholic University of America in molecular biology with a concentration in bio-medical science. He earned an M.S. from Johns Hopkins University in molecular biology with a concentration in biotechnology. His bachelors degree is from Shepherd University with a major in biology and minor in chemistry. Dr. Cherry career led him to become a scientific program director in the Office of Scientific Operations, NCI. Then, in 2020, Dr. Cherry was recruited to lead the NIAID Research Technology Branch.
Dr. Richard Apps obtained his Ph.D. from Cambridge, England, characterizing human immune responses at the maternal-fetal interface. He then studied HIV disease, as a postdoctoral fellow at NCI and Assistant Professor at George Washington University, identifying impacts of human variation and viral evasion during human infections. With this interest in phenotyping primary human samples he joined the CHI in 2018, focusing on applying the multi-modal high dimensional technologies available here to investigate immune function. Visit the National Library of Medicine for a list of publications.